https://openbionews.com/companies/tubulis-technologies/
Tubulis Technologies | Company Profile | OpenBio News
Tubulis is a biotechnology company developing a new generation of antibody-drug conjugates (ADCs) for the treatment of cancer. Its proprietary platforms —...
company profiletubulistechnologiesnews
https://salestools.io/de/report/tubulis-361m-series-c-2025
Tubulis Raises $361M Series C to Transform | SalesTools AI
Oct 22, 2025 - Detailed analysis of Tubulis's $361M Series C funding round, investor details, and market impact in the Biotech sector.. Explore detailed market intelligence...
series ctubulisraisestransform